NEW NORMAL: Big drugmakers can no longer churn out drugs for the masses and double-digit profit increases. Now, they're having to develop drugs for smaller patient groups and hold up the bottom line with relentless cost-cutting.
NEW VOCABULARY: Buzzwords such as "blockbuster" are passe, with "headwinds," "austerity" and "efficiency" now in vogue.
NEW MANTRA: Pharmaceutical executives are stressing how "shareholder friendly" they are, soothing investors with large dividends and more share buybacks, meant to raise both share prices and earnings per share.
scarecrow festival oklahoma state football oklahoma state football case mccoy case mccoy kristin davis kristin davis
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.